Page 53 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் நுஃபையீல்ட் துறை ஆஃப் பாப்யுலேஶந் ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் நுஃபையீல்ட் துறை ஆஃப் பாப்யுலேஶந் ஆரோக்கியம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் நுஃபையீல்ட் துறை ஆஃப் பாப்யுலேஶந் ஆரோக்கியம் Today - Breaking & Trending Today

Number of twins being born globally at 'all-time high', medical study shows

Number of twins being born globally at all-time high , medical study shows
Posted
FriFriday 12
More than 1.6 million twins are now being born every year, researchers say.
(
Share
Print text only
Cancel
Almost one in 40 children are being born twins more than ever before mainly due to the rapid rise of medically assisted reproduction, according to new medical research.
Key points:
As did mothers giving birth at an older age, when twinning rates are higher
Researchers gathered data from 135 countries from 2010-2015
More than 1.6 million twins are now being born every year, researchers said in a paper published by scientific journal Human Reproduction. ....

Christiaan Monden , Jeroen Smits , Oxford University , Saharan Africa , Medi Cal , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , மேதி கலோரி ,

US Has Unused Vaccine, and Europe Wants It

There's no approval yet for the Oxford-AstraZeneca vaccine in the States, but in many countries there is—and those countries are miffed that in the meantime, the US. ....

United States , New York , New York Times , European Union , Coronavirus Vaccine , ஒன்றுபட்டது மாநிலங்களில் , புதியது யார்க் , புதியது யார்க் முறை , ஐரோப்பிய தொழிற்சங்கம் , தடுப்பு மருந்துகள் ,

All You Need to Know: Blood Thinners & COVID Vaccines | EU-AstraZeneca COVID Vaccine Link Explained

Comments
On Thursday, 11 March, Norway, Denmark and some other European countries suspended the use of the Oxford-AstraZeneca COVID vaccine post reports of blood clotting in some vaccine recipients. There were also reports that a 50-year-old man had died in Italy after developing deep vein thrombosis (DVT) following a dose of the jab.
However, the EU s medicines regulator said that there is no indication that the vaccine is linked to an increased risk of blood clots, reported
IANS. It said the number of cases in vaccinated people was no higher than in the general population.
“There is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine. The vaccine’s benefits continue to outweigh its risks and the vaccine can continue to be administered while investigation of cases of thromboembolic events is ongoing,”European Medicines Agency (EMA) said on Thursday, 11 March. ....

United Kingdom , Pramod Kumar , Phil Bryan , Regulatory Agency , Should India , Eu Astrazeneca , European Union , Co Vid , Covid Vaccine , Blood Thinners , Blood Thinners Faq , Blood Clot , Astrazeneca Blood Clots , Astrazeneca Vaccine Blood Clot , Denmark Suspends Astrazeneca , Covid 19 Vaccine , Corona Vaccine , Oxford Astrazeneca , ஒன்றுபட்டது கிஂக்டம் , பிரமோத் குமார் , பில் பிரையன் , வேண்டும் இந்தியா , ஐரோப்பிய தொழிற்சங்கம் , இணை வித் , இரத்தம் உறைதல் , கொரோனா தடுப்பூசி ,

The Latest: Poll: People of color bear virus economic brunt

WASHINGTON The Biden administration says it has the authority to direct states to. ....

United States , Hong Kong , United Kingdom , Serbia General , Noord Holland , Sai Ying Pun , Hong Kong General , Sofiya Grad , Great Britain , Zoran Gojkovic , Boyko Borissov , Steffen Seibert , Sebastian Kurz , Joe Biden , Jens Spahn , Centers For Disease , European Union , European Commission , European Medicines Agency , Hispanic Americans , Disease Control , President Joe , Austrian Chancellor Sebastian Kurz , Central Europe , Minister Jens Spahn , Minister Boyko Borissov ,

India to retain 4-6 week dosing gap for Covid-19 vaccines

Countries such as the UK and Canada that are also using the vaccine developed by AstraZeneca and Oxford have extended the interval between the two doses to as long as four months. Serum Institute of India manufactures this vaccine in India and exports it to many markets. ....

United Kingdom , World Health Organization , National Technical Advisory Group On Immunisation , Serum Institute Of India , National Expert Group , Vaccine Administration , National Technical Advisory Group , ஒன்றுபட்டது கிஂக்டம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , சீரம் நிறுவனம் ஆஃப் இந்தியா , தேசிய நிபுணர் குழு ,